Clinical Trial Update: Temsirolimus Adventitial Delivery to Improve Angiographic Outcomes Below the Knee (TANGO) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating temsirolimus delivered adventitially to improve angiographic outcomes in chronic limb ischemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Limb Ischemia

Drugs mentioned

• Temsirolimus (temsirolimus)

Snippet

Sponsor: Mercator MedSystems, Inc. | Conditions: Chronic Limb Ischemia | Phase 2 | Status: UNKNOWN